Medical Cannabis, from cultivation to pharmaceuticals; inspired by the patient.
DanCann Pharma challenge the status quo when developing and supplying medical cannabis, with focus on environment, consistency and quality.
DanCann Pharma challenge the status quo when developing and supplying medical cannabis, with focus on environment, consistency and quality.
DanCann Pharma A/S was founded in 2018 and is a Danish pharmaceutical biotechnology company powered by cannabinoids. DanCann Pharma is focused on discovering, developing, manufacturing, and commercializing of novel cannabinoid therapeutics in a broad range of disease areas.
IPO at Spotlight Stock Market
To accelerate and develop DanCann Pharma A/S we are now raising further capital with an Initial Public Offering (IPO) at Spotlight Stock Market. Join our journey – from idea to launch – and help us change the world.
Find out moreCultivation technique developed by NASA
Until now, the Medical Cannabis industry has been reliant on old, refurbished greenhouses and single-tier cultivation. Instead, DanCann Pharma is utilizing the principles of Vertical Farming and Controlled Environment Agriculture.
Find out moreRelease the true potential
DanCann Pharma has a differentiated approach to the industry, by targeting supply and research of rare cannabinoids (APIs) for new, unexplored treatment options.
Find out more